Harbor Capital Advisors »

Revance Therapeutics shares owned by Harbor Capital Advisors

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Harbor Capital Advisors from 13F filings

Historical chart of Harbor Capital Advisors investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Harbor Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Harbor Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $487k 55k 8.79
2023-09-30 $470k 41k 11.47
2023-06-30 $802k 32k 25.31